dibekacin - CISMeF

Preferred Label : dibekacin;

MeSH definition : Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties.;

MeSH synonym : 3',4'-dideoxykanamycin b; 3',4' dideoxykanamycin b; b, 3',4'-dideoxykanamycin; dideoxykanamycin b;

MeSH hyponym : orbicin; dideoxykanamycine; dibekacin sulfate; Sulfate, Dibekacin; Dibekacin Sulphate; Sulphate, Dibekacin;

MeSH CAS label : D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy-;

MeSH Related Number : 34493-98-6 (Dibekacin); dibekacin sulfate; A0869I992Z;

Registry Number MeSH : 34493-98-6;

Related CAS MeSH : A0869I992Z (Dibekacin sulfate);

Codes EINECS : 252-064-6;

Is substance : O;

UNII : 45ZFO9E525;

InChIKey : JJCQSGDBDPYCEO-XVZSLQNASA-N;

Details

Origin ID

D003982;

UMLS CUI

C0012024;

ATC code(s)
- dibekacin [ATC Code]
ATC code(s)
- dibekacin [ATC Code]
- dibekacin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- dibekacin [EMDN type]
CISMeF manual mappings
- dibekacin [Substance BNPC]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
Record concept(s)
- dibekacin [MeSH concept]
- dibekacin sulfate [MeSH concept]
- dideoxykanamycine [MeSH concept]
- orbicin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-N-(5-amino-4-fluoro-2-hydroxypentanoyl)dibekacin [MeSH Supplementary Concept]
- 2''-amino-2''-deoxyarbekacin [MeSH Supplementary Concept]
- 2'-N-acetylarbekacin [MeSH Supplementary Concept]
- 5-deoxy-5,5-difluoroarbekacin [MeSH Supplementary Concept]
- 5-deoxy-5-fluoroarbekacin [MeSH Supplementary Concept]
- 6'-N-formimidoyldibekacin [MeSH Supplementary Concept]
- BF5 diluent [MeSH Supplementary Concept]
- arbekacin [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Dibekacin [ICD-11 Extension code]
- Dibekacin [NCIt concept]
- Dibekacin [LOINC component]
- dibekacin [ATC Code]
- dibekacin [Substance BNPC]
- dibekacin [ATC Code]
Validated automatic mappings to BTNT
- Dibekacin sulfate [SMS substance]
- dibekacin [ATC Code]
- dibekacin [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients